US 11708423
Chimeric engulfment receptor molecules and methods of use
granted A61KA61K40/13A61K40/24
Quick answer
US patent 11708423 (Chimeric engulfment receptor molecules and methods of use) held by Cero Therapeutics Holdings, Inc. expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cero Therapeutics Holdings, Inc.
- Grant date
- Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K40/13, A61K40/24, A61K40/31, A61K40/32